Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Vaccine|June 26, 2014
Lasting immune memory against hepatitis B following challenge 10-11 years after primary vaccination with either three doses of hexavalent DTPa-HBV-IPV/Hib or monovalent hepatitis B vaccine at 3, 5 and 11-12 months of ageMária Avdicova, Priya D Crasta, Karin Hardt, et al.
Vaccine|February 22, 2012
Immunogenicity of Infanrix™ hexa administered at 3, 5 and 11 months of ageOlivier Van Der Meeren, Sherine Kuriyakose, Devayani Kolhe, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|May 27, 2009
Primary and booster immunization with a diphtheria, tetanus, acellular pertussis, hepatitis B (DTPa-HBV) and Haemophilus influenzae type b (Hib) vaccine administered separately or together is safe and immunogenicHelen Marshall, Peter McIntyre, Don Roberton, et al.
Vaccine|April 18, 2015
Immunogenicity and reactogenicity of a decennial booster dose of a combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and inactivated poliovirus booster vaccine (dTpa-IPV) in healthy adultsMartina Kovac, Niraj Rathi, Sherine Kuriyakose, et al.
Human Vaccines & Immunotherapeutics|June 5, 2013
Long-term anti-HBs antibody persistence following infant vaccination against hepatitis B and evaluation of anamnestic response: a 20-year follow-up study in ThailandYong Poovorawan, Voranush Chongsrisawat, Apiradee Theamboonlers, et al.
Vaccines|September 8, 2015
Sustaining Vaccine Confidence in the 21st CenturyKarin Hardt, Ruprecht Schmidt-Ott, Steffen Glismann, et al.
Human Vaccines & Immunotherapeutics|February 14, 2012
Seventeen-year antibody persistence in adults primed with two doses of an inactivated hepatitis A vaccineKoen Van Herck, Priya Diana Crasta, Marc Messier, et al.
Vaccine|February 11, 2014
Model based estimates of long-term persistence of inactivated hepatitis A vaccine-induced antibodies in adultsNiel Hens, Aklilu Habteab Ghebretinsae, Karin Hardt, et al.
Human Vaccines|February 18, 2009
Safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine for cervical cancer prevention: a pooled analysis of 11 clinical trialsDominique Descamps, Karin Hardt, Bart Spiessens, et al.
Human Vaccines & Immunotherapeutics|July 11, 2012
Persistence and immune memory to hepatitis B vaccine 20 years after primary vaccination of Thai infants, born to HBsAg and HBeAg positive mothersYong Poovorawan, Voranush Chongsrisawat, Apiradee Theamboonlers, et al.
Pageof 4